Aerie Pharmaceuticals reported $-33307000 in Pre-Tax Profit for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Adamas Pharmaceuticals ADMS:US -19518000 7.17M
Aerie Pharmaceuticals AERI:US $ -33.31M 2.2M
Alimera Sciences ALIM:US $ -4.35M 10.06M
Amarin AMRN:US $ -12.97M 21.83M
Antares Pharma ATRS:US $ 7.22M 1.66M
Bluebird Bio BLUE:US $ -216.93M 14.49M
Cara Therapeutics CARA:US $ -1013000 29.73M
Coherus Biosciences CHRS:US $ -38.53M 11.22M
Endo International Ordinary Shares ENDP:US $ 220.65M 39.03M
Flexion Therapeutics FLXN:US $ -30312000 8.1M
Insmed INSM:US $ -115292000 1.41M
Mirati Therapeutics MRTX:US $ -76.76M 89.68M
Novartis NOVN:VX SF 4544M 120M
Regeneron Pharmaceuticals REGN:US $ 1822.2M 2076.1M
Revance Therapeutics RVNC:US $ -74.38M 2.18M
Supernus Pharmaceuticals SUPN:US $ 28.96M 2.28M
Teva Pharmaceutical Industries TEVA:US $ 807M 13M
Zoetis ZTS:US $ 717M 11M
Zogenix ZGNX:US $ -58M 0.89M